DERIVATIVE FINANCIAL INSTRUMENTS (Details) (USD $)	3 Months Ended			9 Months Ended				3 Months Ended		9 Months Ended		9 Months Ended		1 Months Ended	3 Months Ended			8 Months Ended	9 Months Ended							0 Months Ended	3 Months Ended			0 Months Ended	1 Months Ended
	Sep. 30, 2012	Sep. 25, 2011	Mar. 27, 2011	Sep. 30, 2012	Sep. 25, 2011	Dec. 31, 2011	Mar. 25, 2011	Sep. 25, 2011 Swap [Member] Interest Rate Swap [Member] Not Designated as Hedging Instrument [Member]	Mar. 27, 2011 Swap [Member] Interest Rate Swap [Member] Not Designated as Hedging Instrument [Member]	Sep. 25, 2011 Swap [Member] Interest Rate Swap [Member] Not Designated as Hedging Instrument [Member]	Mar. 25, 2011 Swap [Member] Interest Rate Swap [Member] Not Designated as Hedging Instrument [Member]	Sep. 30, 2012 Warrant [Member]	Sep. 25, 2011 Warrant [Member]	Sep. 30, 2011 2008 Warrants [Member]	Sep. 30, 2012 2008 Warrants [Member]	Jul. 01, 2012 2008 Warrants [Member]	Apr. 01, 2012 2008 Warrants [Member]	Aug. 28, 2011 2008 Warrants [Member]	Sep. 30, 2012 2008 Warrants [Member]	Sep. 25, 2011 2008 Warrants [Member]		Sep. 16, 2011 2008 Warrants [Member]	Mar. 31, 2011 2008 Warrants [Member]	Dec. 31, 2009 2008 Warrants [Member]	Dec. 31, 2008 2008 Warrants [Member]	Mar. 31, 2011 March 2011 Warrants [Member]	Jun. 26, 2011 March 2011 Warrants [Member]	Mar. 31, 2011 March 2011 Warrants to TCOMF2 [Member]	Apr. 27, 2011 March 2011 Warrants To Northcreek [Member]	Sep. 16, 2011 September 2011 Warrants [Member]	Sep. 30, 2011 September 2011 Warrants [Member]
Interest Rate Swap Agreements [Abstract]
Number of interest rate swap agreements									2
Number of swap agreements determined to be ineffective and de-designated			2	2
Cash settlement on derivatives									$ 1,100,000
Fair value of interest rate swap agreements											1,100,000
Change in fair value of de-designated swaps recognized in earnings										100,000
Decrease in derivative liability										(100,000)
Number of interest rate derivatives terminated							2				2
Amortized losses recognized in interest expense					700,000					700,000
Amortization of losses on swaps included in other comprehensive income as of de-designation date					100,000			0		100,000
Unamortized loss on swaps due to forecasted swap transactions probable of not occurring					600,000					600,000
Warrants Subject to Revaluation [Abstract]
Number of shares of common stock issuable upon exercise (in shares)														328,169		74,319	148,638	413,996				419,646	496,397	483,742	474,049					135,000
Exercise price of warrants (in dollars per share)																						$ 0.94	$ 0.96	$ 0.98	$ 1.00					$ 0.01
Warrants, expiration date																										Mar. 31, 2016				Mar. 31, 2016
Number of members of Company's former bank lending group who exercised warrants														1		1	3	2	1
Debt discount	(685,000)			(685,000)		(832,000)																				700,000				300,000
Number of warrants exercised, gross (in shares)														91,477	74,319	74,319	179,531	82,401	74,319									125,000	125,000	135,000
Exercise price of shares issued (in dollars per share)																												$ 0.01	$ 0.01	$ 0.01
Net shares of common stock in the aggregate issued (in shares) from the exercise of warrants														45,881		69,106	154,109	45,175	68,641								250,000
Fair value of warrants exercised and reclassified to shareholders' equity												(2,922,000)	(745,000)	100,000	800,000	1,000,000	1,100,000	100,000	800,000								600,000				300,000
Assumptions used to determine change in fair value of 2008 Warrants [Abstract]
Stock trading value (in dollars per share)																				$ 1.90	[1]
Risk-free interest rate (in hundredths)																				0.89%
Expected warrant remaining life																				4 years 6 months
Price volatility (in hundredths)																				108.67%
Change in fair value of outstanding warrants [Roll Forward]
Balance at beginning of period												1,191,000	770,000
Fair value of March and September 2011 Warrants (debt discount)												0	954,000
Reclassification of fair value of exercised warrants to shareholders' equity												(2,922,000)	(745,000)	100,000	800,000	1,000,000	1,100,000	100,000	800,000								600,000				300,000
Change in fair value, included in earnings	73,000	69,000		(1,731,000)	76,000							1,731,000	(76,000)
Balance at end of period												$ 0	$ 903,000

[1] Represents the closing market price of the Company's common stock on September 23, 2011 (last trading day of the period on the NASDAQ stock market).